Abstract
Modern gastrointestinal surgery has changed notably with respect to surgical modality since the advent of endoscopic surgery. The introduction of endoscopic surgery in rectal cancer treatment has enabled “better visualization of structures that could not be seen with conventional techniques,” especially in the deep areas of the narrow pelvic cavity. Good surgical operation under magnified vision that was not possible with laparotomy became possible. As a result, laparoscopic total mesorectal excision (TME) has now been standardized as a procedure for the treatment of rectal cancer. Several randomized comparative studies from around the world have recently been published that have shown that compared to laparotomy, laparoscopic surgery for rectal cancer is associated with certain concerns regarding the technique’s application toward curative-intent rectal resection. This shows that laparoscopic surgery is a complex surgical procedure requiring good surgical skills. Even when a magnified view is obtained under laparoscopic assistance, one cannot deny that restrictions remain in the manipulation of forceps and dissectors in the deep pelvic areas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bonjer HJ, Deijen CL, Haglind E, COLOR II Study Group. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med. 2015;373(2):194.
Jeong SY, Park JW, Nam BH, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol. 2014;15(7):767–74.
Stevenson AR, Solomon MJ, Lumley JW, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA. 2015;314(13):1356–63.
Fleshman J, Branda M, Sargent DJ, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA. 2015;314(13):1346–55. Martin-Perez B, Andrade-Ribeiro GD, Hunter L, Atallah S. A systematic review of transanal minimally invasive surgery (TAMIS) from 2010 to 2013. Tech Coloproctol. 2014;18:775–88.
De Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernandez M, Delgado S, et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to-up” total mesorectal excision (TME)–short-term outcomes in the first 20 cases. Surg Endosc. 2013;27:3165–72.
Atallah S, Martin-Perez B, Albert M, deBeche-Adams T, Nassif G, Hunter L, et al. Transanal minimally invasive surgery for total mesorectal excision (TAMIS-TME): results and experience with the first 20 patients undergoing curative-intent rectal cancer surgery at a single institution. Tech Coloproctol. 2014;18:473–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ito, M. (2019). Key Aspects of the Abdominal Dissection. In: Atallah, S. (eds) Transanal Minimally Invasive Surgery (TAMIS) and Transanal Total Mesorectal Excision (taTME). Springer, Cham. https://doi.org/10.1007/978-3-030-11572-2_25
Download citation
DOI: https://doi.org/10.1007/978-3-030-11572-2_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-11571-5
Online ISBN: 978-3-030-11572-2
eBook Packages: MedicineMedicine (R0)